{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:18:47Z","timestamp":1787318327649,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2023R1A2C2002380"],"award-info":[{"award-number":["NRF-2023R1A2C2002380"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.intimp.2025.114660","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T09:16:30Z","timestamp":1744622190000},"page":"114660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Oleoylethanolamide ameliorates collagen-induced rheumatoid arthritis via activation of GPR119"],"prefix":"10.1016","volume":"155","author":[{"given":"Jung-Eun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Soon","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114660_bb0005","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"23","key":"10.1016\/j.intimp.2025.114660_bb0010","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"10086","key":"10.1016\/j.intimp.2025.114660_bb0015","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.intimp.2025.114660_bb0020","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114660_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041291","article-title":"The burden of rheumatoid arthritis: findings from the 2019 global burden of diseases study and forecasts for 2030 by Bayesian age-period-cohort analysis","volume":"12","author":"Cai","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2025.114660_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102400","article-title":"The etiology of rheumatoid arthritis","volume":"110","author":"Scherer","year":"2020","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.intimp.2025.114660_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020905","article-title":"Rheumatoid arthritis: pathogenic roles of diverse immune cells","volume":"23","author":"Jang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2025.114660_bb0040","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1177\/1071100715611176","article-title":"Inflammatory cytokines and matrix metalloproteinases in the synovial fluid after intra-articular ankle fracture","volume":"36","author":"Adams","year":"2015","journal-title":"Foot Ankle Int."},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4049\/jimmunol.161.1.409","article-title":"Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines","volume":"161","author":"Chabaud","year":"1998","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114660_bb0050","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.114660_bb0055","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/JLB.4RU0619-197R","article-title":"Th17 cell pathogenicity and plasticity in rheumatoid arthritis","volume":"106","author":"Yang","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta","volume":"204","author":"Nadkarni","year":"2007","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.114660_bb0065","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/ard.2006.068320","article-title":"Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis","volume":"66","author":"Behrens","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2025.114660_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106731","article-title":"JAK-STAT inhibitors: immersing therapeutic approach for management of rheumatoid arthritis","volume":"86","author":"Singh","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4062\/biomolther.2016.160","article-title":"Sphingosine 1-phosphate receptor modulators and drug discovery","volume":"25","author":"Park","year":"2017","journal-title":"Biomol Ther (Seoul)"},{"issue":"11","key":"10.1016\/j.intimp.2025.114660_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115866","article-title":"Free fatty acid 4 receptor activation attenuates collagen-induced arthritis by rebalancing Th1\/Th17 and Treg cells","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.intimp.2025.114660_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413393","article-title":"Blocking the Sphingosine-1-phosphate receptor 2 (S1P(2)) reduces the severity of collagen-induced arthritis in DBA-1J mice","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114660_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111800","article-title":"NJK14047 inhibition of p38 MAPK ameliorates inflammatory immune diseases by suppressing T cell differentiation","volume":"130","author":"Lee","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114660_bb0095","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3389\/fphar.2019.01085","article-title":"Sphingosine-1-phosphate receptor subtype 1 (S1P1) modulator IMMH001 regulates adjuvant- and collagen-induced arthritis","volume":"10","author":"Jin","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4049\/jimmunol.1101537","article-title":"Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities","volume":"188","author":"Fujii","year":"2012","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114660_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218090","article-title":"Upregulation of sphingosine-1-phosphate receptor 3 on fibroblast-like synoviocytes is associated with the development of collagen-induced arthritis via increased interleukin-6 production","volume":"14","author":"Inoue","year":"2019","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.intimp.2025.114660_bb0110","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11745-002-0978-z","article-title":"Anandamide and other N-acylethanolamines in human tumors","volume":"37","author":"Schmid","year":"2002","journal-title":"Lipids"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.114660_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0009-3084(00)00192-4","article-title":"N-Acylethanolamines and precursor phospholipids - relation to cell injury","volume":"108","author":"Hansen","year":"2000","journal-title":"Chem. Phys. Lipids"},{"issue":"6507","key":"10.1016\/j.intimp.2025.114660_bb0120","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.intimp.2025.114660_bb0125","doi-asserted-by":"crossref","first-page":"20869","DOI":"10.1074\/jbc.M110813200","article-title":"Astrocytes in culture produce anandamide and other acylethanolamides","volume":"277","author":"Walter","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.114660_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031034","article-title":"GPR119 and GPR55 as receptors for fatty acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide","volume":"22","author":"Im","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.114660_bb0135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Overton","year":"2006","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/me.2009-0239","article-title":"N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119","volume":"24","author":"Chu","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114660_bb0145","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/1087057113475480","article-title":"Screening \u03b2-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors","volume":"18","author":"Southern","year":"2013","journal-title":"J. Biomol. Screen."},{"issue":"3","key":"10.1016\/j.intimp.2025.114660_bb0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1017\/S1461145713001259","article-title":"The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental parkinsonism","volume":"17","author":"Gonzalez-Aparicio","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085337","article-title":"Atheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDL","volume":"9","author":"Fan","year":"2014","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.intimp.2025.114660_bb0160","first-page":"6301","article-title":"Inhibitory effects of oleoylethanolamide (OEA) on H\u2082O\u2082-induced human umbilical vein endothelial cell (HUVEC) injury and apolipoprotein E knockout (ApoE\u2212\/\u2212) atherosclerotic mice","volume":"8","author":"Ma","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114660_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu111","article-title":"Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats","volume":"18","author":"Sayd","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114660_bb0170","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/adb.12365","article-title":"Oleoylethanolamide prevents neuroimmune HMGB1\/TLR4\/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration","volume":"22","author":"Ant\u00f3n","year":"2017","journal-title":"Addict. Biol."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2025.114660_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pain.2007.03.008","article-title":"Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain","volume":"133","author":"Suard\u00edaz","year":"2007","journal-title":"PAIN\u00ae"},{"key":"10.1016\/j.intimp.2025.114660_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104770","article-title":"Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: effects on metabolic parameters, anthropometric indices, and expression of PPAR-\u03b1, UCP1, and UCP2 genes","volume":"156","author":"Tutunchi","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.114660_bb0185","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jphs.2014.12.001","article-title":"Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats","volume":"127","author":"Li","year":"2015","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12902-024-01738-7","article-title":"The effect of Oleoylethanolamide supplementation on lipid profile, fasting blood sugar and dietary habits in obese people: a randomized double-blind placebo-control trial","volume":"24","author":"Ostadrahimi","year":"2024","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.intimp.2025.114660_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109330","article-title":"Serum proteome and metabolome uncover novel biomarkers for the assessment of disease activity and diagnosing of systemic lupus erythematosus","volume":"251","author":"He","year":"2023","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114660_bb0200","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/ar2401","article-title":"Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis","volume":"10","author":"Richardson","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2025.114660_bb0205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s13075-015-0845-5","article-title":"Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner","volume":"17","author":"Lowin","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2025.114660_bb0210","doi-asserted-by":"crossref","first-page":"479","DOI":"10.15171\/apb.2018.056","article-title":"Oleoylethanolamide supplementation reduces inflammation and oxidative stress in obese people: a clinical trial, Adv","volume":"8","author":"Payahoo","year":"2018","journal-title":"Pharm. Bull."},{"issue":"18","key":"10.1016\/j.intimp.2025.114660_bb0215","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1111\/jcmm.16854","article-title":"Activation of formyl peptide receptor 1 elicits therapeutic effects against collagen-induced arthritis","volume":"25","author":"Park","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0220","first-page":"129","article-title":"Oleoylethanolamide enhances \u03b2-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat","volume":"7","author":"Su\u00e1rez","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.intimp.2025.114660_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.599646","article-title":"Long-acting glucagon-like Peptide-1 receptor agonists suppress voluntary alcohol intake in male Wistar rats","volume":"14","author":"Marty","year":"2020","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.intimp.2025.114660_bb0230","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12712","article-title":"Acacetin regulated the reciprocal differentiation of Th17 cells and Treg cells and mitigated the symptoms of collagen-induced arthritis in mice","volume":"88","author":"Liu","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2025.114660_bb0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13020-020-00311-3","article-title":"Pien Tze Huang alleviate the joint inflammation in collagen-induced arthritis mice","volume":"15","author":"Deng","year":"2020","journal-title":"Chin. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.114660_bb0240","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/annrheumdis-2020-219247","article-title":"\u2018SMASH\u2019 recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models","volume":"80","author":"Hayer","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2025.114660_bb0245","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/ard.2010.141077","article-title":"Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis","volume":"70","author":"Corr","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0250","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00281-003-0131-5","article-title":"The KRN mouse model of inflammatory arthritis","volume":"25","author":"Kyburz","year":"2003","journal-title":"Springer Semin. Immunopathol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114660_bb0255","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.20021850","article-title":"Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling","volume":"197","author":"Choe","year":"2003","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0260","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar1028","article-title":"Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols","volume":"6","author":"Douni","year":"2004","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2025.114660_bb0265","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114660_bb0270","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2025.114660_bb0275","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/FJC.0000000000000413","article-title":"N-Oleoylethanolamine reduces inflammatory cytokines and adhesion molecules in TNF-\u03b1-induced human umbilical vein endothelial cells by activating CB2 and PPAR-\u03b1","volume":"68","author":"Xu","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114660_bb0280","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaci.2023.09.043","article-title":"Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma","volume":"153","author":"Kwon","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114660_bb0285","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2005.02.013","article-title":"Oleoylethanolamide, an endogenous PPAR-\u03b1 agonist, lowers body weight and hyperlipidemia in obese rats","volume":"48","author":"Fu","year":"2005","journal-title":"Neuropharmacology"},{"issue":"6953","key":"10.1016\/j.intimp.2025.114660_bb0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-\u03b1","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"issue":"6860","key":"10.1016\/j.intimp.2025.114660_bb0295","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35102582","article-title":"An anorexic lipid mediator regulated by feeding","volume":"414","author":"Rodr\u00edguez de Fonseca","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.114660_bb0300","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41232-018-0086-5","article-title":"Endocannabinoids and related N-acylethanolamines: biological activities and metabolism","volume":"38","author":"Tsuboi","year":"2018","journal-title":"Inflamm Regen"},{"issue":"9","key":"10.1016\/j.intimp.2025.114660_bb0305","doi-asserted-by":"crossref","first-page":"E1409","DOI":"10.1210\/jc.2011-0647","article-title":"2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans","volume":"96","author":"Hansen","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.intimp.2025.114660_bb0310","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2337\/db08-1237","article-title":"GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell","volume":"58","author":"Lauffer","year":"2009","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.intimp.2025.114660_bb0315","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1677\/JOE-08-0453","article-title":"GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis","volume":"201","author":"Lan","year":"2009","journal-title":"J. Endocrinol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114660_bb0320","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","article-title":"Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule","volume":"36","author":"Ben Nasr","year":"2024","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0325","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.intimp.2025.114660_bb0330","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/jdi.14346","article-title":"One step closer to solving the mystery of the anti-inflammatory effects of glucagon-like peptide-1 receptor agonists","volume":"16","author":"Watada","year":"2025","journal-title":"J Diabetes Investig"},{"issue":"10","key":"10.1016\/j.intimp.2025.114660_bb0335","doi-asserted-by":"crossref","first-page":"18392","DOI":"10.1002\/jcp.28474","article-title":"Immunomodulatory effect of oleoylethanolamide in dendritic cells via TRPV1\/AMPK activation","volume":"234","author":"Yao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2025.114660_bb0340","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916662886","article-title":"High levels of endogenous lipid mediators (N-acylethanolamines) in women with chronic widespread pain during acute tissue trauma","volume":"12","author":"Stensson","year":"2016","journal-title":"Mol. Pain"},{"issue":"1","key":"10.1016\/j.intimp.2025.114660_bb0345","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12944-017-0505-7","article-title":"Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study","volume":"16","author":"Stensson","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"6","key":"10.1016\/j.intimp.2025.114660_bb0350","article-title":"Plasma and interstitial levels of endocannabinoids and N-acylethanolamines in patients with chronic widespread pain and fibromyalgia: a systematic review and meta-analysis","volume":"7","author":"Kurlyandchik","year":"2022","journal-title":"Pain Rep"},{"issue":"7","key":"10.1016\/j.intimp.2025.114660_bb0355","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/gtc.12944","article-title":"Comprehensive lipidomics of lupus-prone mice using LC-MS\/MS identifies the reduction of palmitoylethanolamide that suppresses TLR9-mediated inflammation","volume":"27","author":"Ozaki","year":"2022","journal-title":"Genes Cells"},{"key":"10.1016\/j.intimp.2025.114660_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114258","article-title":"Oleoylethanolamide ameliorates allergic asthma and atopic dermatitis via activation of GPR119","volume":"149","author":"Lee","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114660_bb0365","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.appet.2018.05.129","article-title":"Oleoylethanolamide increases the expression of PPAR-\u0391 and reduces appetite and body weight in obese people: a clinical trial","volume":"128","author":"Laleh","year":"2018","journal-title":"Appetite"},{"issue":"6","key":"10.1016\/j.intimp.2025.114660_bb0370","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1002\/jcp.27913","article-title":"Oleoylethanolamide: a novel pharmaceutical agent in the management of obesity-an updated review","volume":"234","author":"Laleh","year":"2019","journal-title":"J. Cell. Physiol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925006502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925006502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:37:19Z","timestamp":1778053039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925006502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":74,"alternative-id":["S1567576925006502"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114660","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oleoylethanolamide ameliorates collagen-induced rheumatoid arthritis via activation of GPR119","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114660"}}